United States · 
Who invested in Latigo Biotherapeutics?
Latigo Biotherapeutics's investors include Cormorant Asset Management, 5AM Ventures, Foresite Capital, Sanofi and Blue Owl.
United States · Series B startup
Who invested in Latigo Biotherapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$150Mraised across 1 round since 2025, from 1 source
- Latest round
- Series B, $150MMar 2025
- Investors
- 5
The rounds
- Mar 2025Series B$150M
Source recordedSEC filing: $50M sold, first sale Jan 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Latigo Biotherapeutics
How much has Latigo Biotherapeutics raised?
Latigo Biotherapeutics has raised $150M across 1 round since 2025.
When did Latigo Biotherapeutics last raise?
Latigo Biotherapeutics's most recent round was a Series B of $150M in Mar 2025.
What was Latigo Biotherapeutics's biggest round?
Its most recent round, $150M in Mar 2025, is also its largest on record.
Who backed Latigo Biotherapeutics first?
Latigo Biotherapeutics's first round on record, in Mar 2025, was backed by Cormorant Asset Management, 5AM Ventures and Foresite Capital and 2 others.
What stage is Latigo Biotherapeutics at?
Latigo Biotherapeutics's latest named round is a Series B, in Mar 2025.
Where is Latigo Biotherapeutics based?
Latigo Biotherapeutics is based in the United States.
Companies like Latigo Biotherapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.